Alector, INC. (ALEC) — 10-Q Filings

10-Q Filings (6)

• Alector Narrows Q3 Loss Amid Revenue Drop, R&D Cuts — Nov 6, 2025 Risk: high
  Alector, Inc. (ALEC) reported a net loss of $34.667 million for the three months ended September 30, 2025, an improvement from the $42.220 million net loss in t
• Alector's Q2 Net Loss Widens to $70.5M Amid R&D Spend — Aug 7, 2025 Risk: high
  Alector, Inc. reported a net loss of $70.5 million for the quarter ended June 30, 2025, a significant increase from the $55.2 million net loss in the prior-year
• Alector, Inc. Files Q1 2025 10-Q — May 8, 2025 Risk: medium
  Alector, Inc. filed its 10-Q for the period ending March 31, 2025. The company, focused on biological products, reported on its financial activities. Key financ
• Alector, Inc. Files Q3 2024 10-Q Report — Nov 6, 2024 Risk: medium
  Alector, Inc. filed its Q3 2024 10-Q report on November 6, 2024, detailing its financial performance and operations for the period ending September 30, 2024. Th
• Alector, Inc. Files Q2 2024 10-Q Report — Aug 7, 2024 Risk: medium
  Alector, Inc. filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance and business operations. The filing details various fin
• Alector, Inc. Files 10-Q for Period Ending March 31, 2024 — May 8, 2024 Risk: medium
  Alector, Inc. (ALEC) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Alector, Inc. filed a 10-Q report for the period ending March 31, 2024. The fi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX